Phastar partnered with an emerging biotech to develop an innovative Bayesian Phase I/II oncology design for a first-in-human clinical trial.

Phastar is an award-winning specialist biometrics and data science CRO, trusted by pharma, biotech, and medical device companies worldwide. With a global team of data specialists, it brings expertise, precision, and pace to every trial – because behind every data point is a patient waiting for treatment. Phastar doesn’t just deliver high-quality clinical trial data. It partners with clients to turn complexity into clarity. Leveraging technology, AI-enhanced analytics, advanced statistical methods, and deep therapeutic expertise, it accelerates regulatory approvals, ensures compliance with global standards and mitigates risk. Phastar has a proven track record in transforming complex data into clear, actionable intelligence, empowering its partners to accelerate drug development. With scalable, tailored solutions, it expedites trials – bringing life-changing therapies to patients faster.